Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mauro

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Blood|April 22, 2008
Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLLDalemari Crowther-Swanepoel, Ruth Wild, Gabrielle Sellick, et al.
Haematologica|September 23, 2017
Clinical relevance of silent red blood cell autoantibodiesFrancesca R Mauro, Fabio Trastulli, Cristiano Alessandri, et al.
Leukemia Research|March 16, 2017
Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemiaFrancesca R Mauro, Fortunato Morabito, Iolanda D Vincelli, et al.
Genes, Chromosomes & Cancer|February 4, 2015
Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212Simona Tavolaro, Teresa Colombo, Sabina Chiaretti, et al.
American Journal of Hematology|April 10, 2016
Clinical characteristics and outcome of patients with autoimmune hemolytic anemia uniformly defined as primary by a diagnostic work-upFrancesca R Mauro, Serelina Coluzzi, Francesca Paoloni, et al.
British Journal of Haematology|December 14, 2011
An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patientsAgostino Cortelezzi, Giuseppe Gritti, Luca Laurenti, et al.
American Journal of Human Genetics|August 5, 2005
A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility lociGabrielle S Sellick, Emily L Webb, Ruth Allinson, et al.
Hematological Oncology|July 24, 2019
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemiaAndrea Visentin, Marina Deodato, Francesca R Mauro, et al.
Haematologica|May 18, 2019
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemiaMichael Steurer, Marco Montillo, Lydia Scarfò, et al.
Blood|February 20, 2014
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractorinessMonica Messina, Ilaria Del Giudice, Hossein Khiabanian, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Blood|April 22, 2008
Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLLDalemari Crowther-Swanepoel, Ruth Wild, Gabrielle Sellick, et al.
Haematologica|September 23, 2017
Clinical relevance of silent red blood cell autoantibodiesFrancesca R Mauro, Fabio Trastulli, Cristiano Alessandri, et al.
Leukemia Research|March 16, 2017
Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemiaFrancesca R Mauro, Fortunato Morabito, Iolanda D Vincelli, et al.
Genes, Chromosomes & Cancer|February 4, 2015
Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212Simona Tavolaro, Teresa Colombo, Sabina Chiaretti, et al.
American Journal of Hematology|April 10, 2016
Clinical characteristics and outcome of patients with autoimmune hemolytic anemia uniformly defined as primary by a diagnostic work-upFrancesca R Mauro, Serelina Coluzzi, Francesca Paoloni, et al.
British Journal of Haematology|December 14, 2011
An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patientsAgostino Cortelezzi, Giuseppe Gritti, Luca Laurenti, et al.
American Journal of Human Genetics|August 5, 2005
A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility lociGabrielle S Sellick, Emily L Webb, Ruth Allinson, et al.
Hematological Oncology|July 24, 2019
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemiaAndrea Visentin, Marina Deodato, Francesca R Mauro, et al.
Haematologica|May 18, 2019
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemiaMichael Steurer, Marco Montillo, Lydia Scarfò, et al.
Blood|February 20, 2014
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractorinessMonica Messina, Ilaria Del Giudice, Hossein Khiabanian, et al.
Pageof 14